Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Drug Deliv Transl Res. 2012 Dec 1;2(6):454–462. doi: 10.1007/s13346-012-0107-x

Table 1.

Characteristics of optimized P-SSMM-VIP and P-SSMM formulations

Formulation Average diameter (nm) Phospholipid content (mM) Paclitaxel concentration (μg/ml) VIP content (mM)
P-SSMM 14.2±0.26 14.8±0.09 999.0±2.10
P-SSMM-VIP 14.5±1.19 15.8±0.07 987.1±22.03 0.854±0.067

values are mean ± SD from three separate formulation preparations